{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:46:24Z","timestamp":1785332784594,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>This study retrospectively investigated the morphological, immunohistochemical and molecular genetic features of papillary renal neoplasm with reverse polarity (PRNRP), a recently described renal tumor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>Eleven cases of PRNRP were collected, and 16 cases of type I and 9 cases of type II papillary renal cell carcinoma were included as a control series. Pathological features were evaluated based on HE staining and immunohistochemistry. <jats:italic>KRAS<\/jats:italic> exon 2 and <jats:italic>BRAF<\/jats:italic> V600E mutations were detected by Real-time PCR and Sanger sequencing. Fluorescence in situ hybridization was conducted for identification of chromosomal abnormalities.<\/jats:p>\n                <jats:p>Hemosiderin deposition was found in a small amount of tumor cells in 6 cases. Multifocal or patchy necrosis (5\/11), small focal invasion of the pseudocapsules or renal parenchyma (6\/11), and breakthrough of renal capsule with nerve invasion (1\/11) were revealed, inconsistent with the previous view that the tumor lacks necrosis and intercellular hemosiderin. Immunohistochemical staining (diffusely positive for CK7 and GATA3, negative for CD117 and vimentin, and negative to weakly positive for P504S) and high frequency of <jats:italic>KRAS<\/jats:italic> mutations in exon 2 (9\/10) supported the identification and inclusion of our cases. Chromosome 7 trisomy (1\/7), chromosome 17 trisomy (0\/7) and chromosome Y deletion (0\/5 male patients) were seldom detected in this tumor.<\/jats:p>\n                <jats:p>All patients were alive without metastasis or recurrence at the end of the follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings may highlight the possibility of a low malignant potential of this emerging entity. We suggest that the tumor be classified as a novel renal cell tumor subtype independent of papillary renal cell carcinoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01235-2","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:36:19Z","timestamp":1661398579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential"],"prefix":"10.1186","volume":"17","author":[{"given":"Tong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enhao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"2","key":"1235_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"WM Linehan","year":"2016","unstructured":"Cancer Genome Atlas Research N, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016;374(2):135\u201345.","journal-title":"N Engl J Med"},{"issue":"6","key":"1235_CR2","first-page":"537","volume":"10","author":"B Delahunt","year":"1997","unstructured":"Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537\u201344.","journal-title":"Mod Pathol"},{"issue":"4","key":"1235_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00428-003-0787-1","volume":"442","author":"Y Allory","year":"2003","unstructured":"Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch. 2003;442(4):336\u201342.","journal-title":"Virchows Arch"},{"issue":"7","key":"1235_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Luders C, Nesi G, Comperat E, et al. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Am J Surg Pathol. 2016;40(7):865\u201375.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1235_CR5","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T, Sedivcova M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38(12):1588\u2013602.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1235_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37(10):1469\u201389.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1235_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","volume":"43","author":"KI Al-Obaidy","year":"2019","unstructured":"Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study. Am J Surg Pathol. 2019;43(8):1099\u2013111.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1235_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/his.14084","volume":"76","author":"K Tong","year":"2020","unstructured":"Tong K, Zhu W, Fu H, Cao F, Wang S, Zhou W, Liu C, Chen D, Fan S, Hu Z. Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei. Histopathol. 2020;76(7):1070\u201383.","journal-title":"Histopathol"},{"key":"1235_CR9","doi-asserted-by":"crossref","unstructured":"Zhou L, Xu J, Wang S, Yang X, Li C, Zhou J, Zhang P, Xu H, Wang C. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases. Int J Surg Pathol. 2020;28(7):728-734.","DOI":"10.1177\/1066896920918289"},{"issue":"10","key":"1235_CR10","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10):1490\u2013504.","journal-title":"Am J Surg Pathol"},{"key":"1235_CR11","volume-title":"AJCC Cancer Staging Manual","year":"2017","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, et al editors. AJCC Cancer Staging Manual. 8th ed. Chicago IL: Springer; 2017.","edition":"8"},{"issue":"12","key":"1235_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/01.pas.0000184821.09871.ec","volume":"29","author":"M Lefevre","year":"2005","unstructured":"Lefevre M, Couturier J, Sibony M, Bazille C, Boyer K, Callard P, Vieillefond A, Allory Y. Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol. 2005;29(12):1576\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1235_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2007.05.016","volume":"39","author":"LP Kunju","year":"2008","unstructured":"Kunju LP, Wojno K, Wolf JS Jr, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol. 2008;39(1):96\u2013101.","journal-title":"Hum Pathol"},{"issue":"3","key":"1235_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1440-1827.2009.02341.x","volume":"59","author":"BH Park","year":"2009","unstructured":"Park BH, Ro JY, Park WS, Jee KJ, Kim K, Gong G, Cho YM. Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: distinct subtype with an indolent clinical course. Pathol Int. 2009;59(3):137\u201346.","journal-title":"Pathol Int"},{"issue":"12","key":"1235_CR15","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1097\/PAS.0000000000000962","volume":"41","author":"RM Saleeb","year":"2017","unstructured":"Saleeb RM, Brimo F, Farag M, Rompre-Brodeur A, Rotondo F, Beharry V, Wala S, Plant P, Downes MR, Pace K, et al. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis. Am J Surg Pathol. 2017;41(12):1618\u201329.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1235_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41379-019-0420-8","volume":"33","author":"SS Kim","year":"2020","unstructured":"Kim SS, Cho YM, Kim GH, Kee KH, Kim HS, Kim KM, Kim JH, Choi C. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma. Mod Pathol. 2020;33(4):690\u20139.","journal-title":"Mod Pathol"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2021.03.009","volume":"112","author":"D Kiyozawa","year":"2021","unstructured":"Kiyozawa D, Kohashi K, Takamatsu D, Yamamoto T, Eto M, Iwasaki T, Motoshita J, Shimokama T, Kinjo M, Oshiro Y, et al. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity. Hum Pathol. 2021;112:48\u201358.","journal-title":"Hum Pathol"},{"issue":"2","key":"1235_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00000478-200002000-00006","volume":"24","author":"AK Avery","year":"2000","unstructured":"Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24(2):203\u201310.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1235_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/00000478-200112000-00003","volume":"25","author":"DK McGregor","year":"2001","unstructured":"McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, Ro JY, Lechago J, Truong LD. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody \u201cRenal Cell Carcinoma Marker.\u201d Am J Surg Pathol. 2001;25(12):1485\u201392.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1235_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00000478-200401000-00007","volume":"28","author":"MS Tretiakova","year":"2004","unstructured":"Tretiakova MS, Sahoo S, Takahashi M, Turkyilmaz M, Vogelzang NJ, Lin F, Krausz T, Teh BT, Yang XJ. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28(1):69\u201376.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1235_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1242\/dev.02184","volume":"133","author":"D Grote","year":"2006","unstructured":"Grote D, Souabni A, Busslinger M, Bouchard M. Pax 2\/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development (Cambridge, England). 2006;133(1):53\u201361.","journal-title":"Development (Cambridge, England)"},{"issue":"6794","key":"1235_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/35019088","volume":"406","author":"H Van Esch","year":"2000","unstructured":"Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature. 2000;406(6794):419\u201322.","journal-title":"Nature"},{"issue":"4","key":"1235_CR23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/0016-5085(93)90272-E","volume":"104","author":"J Benhattar","year":"1993","unstructured":"Benhattar J, Losi L, Chaubert P, Givel JC, Costa J. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology. 1993;104(4):1044\u20138.","journal-title":"Gastroenterology"},{"key":"1235_CR24","doi-asserted-by":"crossref","unstructured":"Al-Obaidy KI, Eble JN, Nassiri M, Cheng L, Eldomery MK, Williamson SR, Sakr WA, Gupta N, Hassan O, Idrees MTm et al. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Mod Pathol. 2020;33(6):1157-1164.","DOI":"10.1038\/s41379-019-0362-1"},{"issue":"6892","key":"1235_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949\u201354.","journal-title":"Nature"},{"issue":"1","key":"1235_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018;23(1):313-326.e315.","journal-title":"Cell Rep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01235-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:39:18Z","timestamp":1661398758000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01235-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01235-2","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}